NDC 30798-856 - Dextrose
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 30798-856
- Package NDCs from labels
- 30798-856-17
- Manufacturer
- Durvet
- Effective date
- 2025-07-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dextrose - Durvet | Durvet | 2025-07-28 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 30798-856-17 | Dextrose | 500 mL in 1 BOTTLE, PLASTIC | INJECTION, SOLUTION | 500 | 6 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | LX22YL083G | DEXTROSE INJECTION, SOLUTION [DURVET] | 4 | |
| ANHYDROUS DEXTROSE | ACTIVE MOIETY | 5SL0G7R0OK | DEXTROSE INJECTION, SOLUTION [DURVET] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | b0f2c9a2-d9d4-4907-a324-e7a26d489f44 | 2025-05-09 | LX22YL083G | |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | a829d4eb-3ec5-453c-b270-793969af15b3 | 2025-05-09 | LX22YL083G | |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | 50fc30a0-0eca-452e-825e-08c2647ccfc1 | 2025-05-08 | LX22YL083G | |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | b2b780d3-26ac-4e7c-a0f2-78991bee32a8 | 2025-05-07 | LX22YL083G | |
| Aspartame/MSG Detox | CHELIDONIUM MAJUS, ARNICA MONTANA, PHYTOLACCA DECANDRA, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, BISPHENOL A (BPA), DEXTROSE, MALTODEXTRIN, SUCRALOSE, ASPARTIC ACID, DIKETOPIPERAZINE, DOPAMINE HYDROCHLORIDE, FORMALINUM, FORMICUM ACIDUM, L-PHENYLALANINE, METHYL ALCOHOL, MONOSODIUM GLUTAMATE | Deseret Biologicals, Inc. | a1dc1bf3-db71-4550-a975-4f146fb94005 | 2025-03-11 | Warnings | LX22YL083G |
| Glucose and Sodium Chloride | DEXTROSE ANHYDROUS AND SODIUM CHLORIDE | Baxter Healthcare Corporation | 1ba918d0-13d0-48bc-8742-658fc0eb47b6 | 2025-01-24 | LX22YL083G | |
| Anticoagulant Citrate Dextrose A ACD-A | ANTICOAGULANT CITRATE DEXTROSE A ACD-A | Arteriocyte Medical Systems, Inc. | b850deac-161f-4bb0-ac7f-bceac2a230c0 | 2025-01-23 | LX22YL083G | |
| ACD A | DEXTROSE MONOHYDRATE, SODIUM CITRATE, AND CITRIC ACID MONOHYDRATE | Terumo BCT Ltd | 570770de-9b48-4fc1-a1ee-06002ca9504f | 2025-01-22 | LX22YL083G | |
| Anticoagulant Citrate Dextrose (ACD-A) | DEXTROSE MONOHYDRATE, SODIUM CITRATE, UNSPECIFIED FORM, AND CITRIC ACID MONOHYDRATE | Terumo BCT, Ltd | 0130d7c8-d067-4528-beb7-166559c33be9 | 2025-01-21 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | BECTON DICKINSON AND COMPANY | c1d0f42e-3494-4217-8f86-e9f34d930e82 | 2025-01-07 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | BECTON DICKINSON AND COMPANY | d3f90d2f-4536-4d32-800b-7a798f8a35db | 2024-11-07 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 68cc9c41-ed24-4f76-8efb-2936ae3ddd8d | 2024-10-29 | Warnings, Adverse reactions | LX22YL083G |
| teruflex blood bag system with diversion blood sampling arm 70 ml cpda-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 86b3a329-c83f-4977-92f5-0e9dfe1872d7 | 2024-10-10 | Warnings | LX22YL083G |
| TERUFLEX BLOOD with Diversion Blood Sampling Arm 70 mL CPDA-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 39f2e11c-5a31-469f-b725-d096c1674421 | 2024-10-03 | Warnings | LX22YL083G |
| TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 02015040-9b71-4dbe-8f8d-e0d0951e8f93 | 2024-09-19 | Warnings | LX22YL083G |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 3c5f0f65-8a54-4a55-ad4e-0f0be97631d7 | 2024-09-15 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | FRESENIUS KABI USA, LLC | 576a22d8-5f2f-497e-80ad-1842ca74bb53 | 2024-08-22 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | c1f72bce-4bef-49db-a8da-f26a703d6748 | 2024-08-15 | Warnings, Adverse reactions | LX22YL083G |
| Isolyte P in Dextrose | DEXTROSE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND POTASSIUM PHOSPHATE, DIBASIC | B. Braun Medical Inc. | 4ea4397c-2fa4-4670-91e6-21ae498c88f7 | 2024-06-24 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride in Lactated Ringers and Dextrose | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE, AND DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | dbed53b7-0109-4561-8342-0178ec8c64b0 | 2024-05-22 | Warnings, Adverse reactions | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.